EXCELLERGY
LIVE

Serial Number

99208934

Owner

Excellergy, Inc.

Attorney

Aaron D. Hendelman

Filing Date

May 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EXCELLERGY Trademark

Serial Number: 99208934

EXCELLERGY is a trademark filed by Excellergy, Inc. on May 29, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Excellergy, Inc.

3000 El Camino Real
Palo Alto, CA 94306

Entity Type: 03

Trademark Details

Filing Date

May 29, 2025

Registration Date

Not Registered

Published for Opposition

November 25, 2025

Goods & Services

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; chemical and biological diagnostic preparations and substances for medical or veterinary purposes used by clinical and medical laboratories in drug discovery and nucleic acid and protein therapeutics

Providing medical information and patient support services, namely, pharmaceutical advice and consultation in the nature of providing online information regarding the diagnostic, prophylactic and therapeutic properties of pharmaceuticals and the treatment and prevention of various illnesses, disorders and maladies; providing health and medical information about pharmaceuticals; information services, namely, providing medical information to patients; providing medical consultancy and advisory services via a global computer network in the fields of pharmaceuticals and various illnesses, disorders and maladies

Biotechnology, medical and scientific research and development services in the field of protein therapeutics and diagnostics; biotechnology research services, namely, protein therapeutics development for applications in the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; biotechnology research services, namely, protein therapeutics development for applications in the treatment of allergies, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; medical, pharmaceutical and scientific research and development services in the field of protein therapeutics and diagnostics

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 20, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 20, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 20, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 20, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
May 29, 2025 MAFR
NEW APPLICATION ENTERED
May 29, 2025 NWAP